Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 26, 2024; 12(18): 3461-3467
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3461
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3461
Variable | Total (n = 80) | CHD (n = 20) | HF (n = 20) | CHD + HF (n = 20) | Control (n = 20) | P value |
Age (yr) | 63.2 ± 9.8 | 64.1 ± 10.4 | 62.3 ± 9.6 | 63.5 ± 9.2 | 62.9 ± 9.9 | 0.87 |
Male | 45 (56.3) | 12 (60.0) | 11 (55.0) | 13 (65.0) | 9 (45.0) | 0.54 |
Hypertension | 52 (65.0) | 14 (70.0) | 13 (65.0) | 15 (75.0) | 10 (50.0) | 0.23 |
Diabetes | 32 (40.0) | 9 (45.0) | 8 (40.0) | 10 (50.0) | 5 (25.0) | 0.28 |
Dyslipidemia | 30 (37.5) | 8 (40.0) | 7 (35.0) | 9 (45.0) | 6 (30.0) | 0.67 |
Smoking | 29 (36.3) | 8 (40.0) | 7 (35.0) | 9 (45.0) | 5 (25.0) | 0.48 |
Clinical presentation | 0.41 | |||||
Stable angina | 37 (46.3) | 10 (50.0) | 8 (40.0) | 11 (55.0) | 8 (40.0) | |
Unstable angina | 27 (33.8) | 8 (40.0) | 7 (35.0) | 8 (40.0) | 4 (20.0) | |
Acute myocardial infarction | 16 (20.0) | 2 (10.0) | 5 (25.0) | 1 (5.0) | 8 (40.0) | |
LVEF | 55.6 ± 9.2 | 57.2 ± 8.6 | 54.1 ± 9.8 | 53.8 ± 9.4 | 56.9 ± 8.9 | 0.59 |
Variable | Total (n = 80) | CHD (n = 20) | HF (n = 20) | CHD + HF (n = 20) | Control (n = 20) | P value |
Cys-C (mg/L) | 1.3 ± 0.4 | 1.5 ± 0.3 | 1.4 ± 0.4 | 1.7 ± 0.4 | 1.0 ± 0.2 | < 0.001 |
MHR | 0.9 × 109 | 1.0 × 109 | 0.9 × 109 | 1.1 × 109 | 0.7 × 109 | < 0.001 |
UA (μmol/L) | 424.2 ± 125.7 | 469.2 ± 119.4 | 437.1 ± 130.6 | 508.5 ± 124.7 | 347.4 ± 89.7 | < 0.001 |
Biomarkers | Cut-off value | Sensitivity | Specificity | PPV | NPV | Accuracy | AUC (95%CI) |
Cys-C for CHD | 1.2 mg/L | 80 | 85 | 80 | 85 | 82.5 | 0.86 (0.77–0.95) |
MHR for CHD | 0.9 × 109 | 85 | 80 | 77 | 87 | 82.5 | 0.87 (0.78–0.96) |
UA for CHD | 389 μmol/L | 75 | 90 | 86 | 81 | 82.5 | 0.86 (0.77–0.95) |
Cys-C for HF | 1.4 mg/L | 85 | 80 | 77 | 87 | 82.5 | 0.88 (0.79–0.97) |
MHR for HF | 1.0 × 109 | 80 | 85 | 80 | 85 | 82.5 | 0.87 (0.78–0.96) |
UA for HF | 449 μmol/L | 80 | 85 | 80 | 85 | 82.5 | 0.88 (0.79–0.97) |
Cys-C for CHD + HF | 1.6 mg/L | 90 | 85 | 82 | 92 | 87.5 | 0.93 (0.86–1.00) |
MHR for CHD + HF | 1.1 × 109 | 85 | 90 | 85 | 90 | 87.5 | 0.91 (0.83–0.99) |
UA for CHD + HF | 508 μmol/L | 85 | 90 | 85 | 90 | 87.5 | 0.92 (0.84–1.00) |
- Citation: Li M, Yuan DH, Yang Z, Lu TX, Zou XB. Serum cystatin C, monocyte/high-density lipoprotein-C ratio, and uric acid for the diagnosis of coronary heart disease and heart failure. World J Clin Cases 2024; 12(18): 3461-3467
- URL: https://www.wjgnet.com/2307-8960/full/v12/i18/3461.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i18.3461